Benyan Luo Selected Research

acetyl- aspartyl- methionyl- glutaminyl- aspartyl- aldehyde

1/2016

RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benyan Luo Research Topics

Disease

7	Ischemic Stroke 06/2022 - 12/2015
7	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 08/2003
6	Brain Ischemia (Cerebral Ischemia) 01/2016 - 04/2012
5	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2022 - 01/2015
5	Cognitive Dysfunction 01/2022 - 01/2016
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2021 - 01/2016
5	Stroke (Strokes) 05/2020 - 03/2014
5	Consciousness Disorders 01/2019 - 01/2016
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Dementia (Dementias) 01/2021 - 01/2016
2	Memory Disorders (Memory Loss) 01/2019 - 04/2012
2	Myasthenia Gravis 01/2018 - 01/2014
2	Persistent Vegetative State (Vegetative State) 01/2018 - 01/2016
2	Ischemia 01/2016 - 01/2013
2	Infarction (Infarctions) 01/2016 - 01/2010
2	Reperfusion Injury 01/2016 - 04/2012
2	Necrosis 01/2016 - 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Brain Injuries (Brain Injury) 02/2021
1	Brain Infarction 02/2021
1	Neuroinflammatory Diseases 02/2021
1	Cerebral Hemorrhage 04/2020
1	Clinical Deterioration 01/2020
1	Glioma (Gliomas) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Muscle Weakness 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018
1	Channelopathies 11/2017
1	Myotonia 11/2017
1	Paralysis (Palsy) 11/2017
1	Myotonic Disorders (Paramyotonia Congenita) 11/2017
1	Glioblastoma (Glioblastoma Multiforme) 02/2016
1	Atrophy 02/2016
1	Corticobasal Degeneration 02/2016
1	Carotid Stenosis (Carotid Artery Stenosis) 02/2016
1	Neoplasms (Cancer) 02/2016

Drug/Important Bio-Agent (IBA)

5	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2016
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2016
3	N-Methylaspartate (NMDA)IBA 01/2022 - 01/2019
3	ApolipoproteinsIBA 12/2021 - 08/2003
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
2	Interleukin-8 (Interleukin 8)IBA 06/2022 - 01/2018
2	Chemokine ReceptorsIBA 06/2022 - 01/2018
2	CytokinesIBA 02/2021 - 04/2012
2	Caspase 8 (Caspase-8)IBA 02/2021 - 01/2016
2	SodiumIBA 01/2021 - 10/2014
2	Sirtuin 1IBA 05/2020 - 01/2020
2	Apolipoproteins E (ApoE)IBA 12/2019 - 08/2003
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2015
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2015
2	MicroRNAs (MicroRNA)IBA 01/2018 - 12/2015
2	Neuroprotective AgentsIBA 01/2016 - 01/2014
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2022
1	Purinergic P2Y2 ReceptorsIBA 01/2022
1	NucleotidesIBA 02/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 10/2020
1	Small Interfering RNA (siRNA)IBA 05/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2020
1	Acetylcarnitine (Alcar)IBA 01/2020
1	N(delta)-acetylornithine (N-acetylornithine)IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	AgmatineIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	LDL CholesterolIBA 01/2020
1	PutrescineIBA 01/2020
1	UridineIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	HMGB1 Protein (HMG1)IBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	Vesicular Transport Adaptor ProteinsIBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Interleukin-8B ReceptorsIBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Sodium Channels (Sodium Channel)IBA 11/2017
1	Voltage-Gated Sodium ChannelsIBA 11/2017
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2017
1	AcetylcholinesteraseIBA 01/2017
1	ProgranulinsIBA 02/2016
1	Cathepsin BIBA 01/2016
1	necrostatin-1IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016

Therapy/Procedure

7	Therapeutics 01/2021 - 05/2012
4	Transcranial Magnetic Stimulation 01/2022 - 01/2016
2	Immunotherapy 01/2019 - 01/2018
1	Activities of Daily Living (ADL) 01/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Cognitive Training 01/2019
1	Transcranial Direct Current Stimulation 01/2019
1	Precision Medicine 01/2018
1	Stents 02/2016
1	Hyperbaric Oxygenation 01/2016